Securities Fraud Complaint Filed Against NRx Pharmaceuticals

M Financial Planning Enters Consent Agreement with Pennsylvania

A securities fraud lawsuit has been filed against NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) for potential securities violations on behalf of shareholders who purchased shares anytime during the period from June 1, 2021 through November 4, 2021.  The release of potentially misrepresentative and misleading information, as well as failure to disclose material adverse facts to the […]